Please Wait.....
Report
Long Read Sequencing Market Size, Share & Trends by Offerings (Consumables, Instruments, Services), Workflow (Sample Prep, Sequencing, Data Analysis), Technology (Nanopore, SMRT), Application (WGS, WES, Epigenetics), Usage (Clinical, Research) - Global Forecast to 2029
Market Report I 2024-08-12 I 307 Pages I MarketsandMarkets
The long-read sequencing market is expected to reach USD 3,129 million in 2029 from USD 758 million in 2024, at a CAGR of 32.8% during the forecast period.
Growth in the long-read sequencing market is mainly driven by factors like increasing collaborations between academic institutions and industry players, decreased cost of sequencing, and continuous technological advancements in long-read sequencing. Moreover, the application of LRS like de novo genome assembly, structural variant detection, transcriptomics, and epigenetics is supporting the market growth. However, the initial cost concern to set up the equipment is impacting the growth of the long-read sequencing market.
"The consumables segment accounted for the largest share by offerings segment in the long-read sequencing market in 2023"
The long-read sequencing market is segmented into consumables, instruments, and services in 2023. The consumables is the segment with the largest share in offerings. The large share of consumables is due to their role in sample preparation, sequencing, and data analysis part of long-read sequencing. As the demand for sequencing increases, it supports the demand for the consumables segment, driving its growth in the market. Still, the instrument segment held the second-largest market share.
"The academic & research institutes segment accounted for the largest share by end-user segment in the long-read sequencing market in 2023"
The long-read sequencing market is segmented into academic & research institutes, pharmaceutical & biotechnologies companies, hospitals, clinics & diagnostics laboratories, and other end users. The academic & research institutes are the segment with the largest share in the end-user segment in 2023. The large share of academic & research institutes is due to the increased demand for whole genome sequencing products, and increased genomics research. However, the pharmaceutical & biotechnological companies accounted for the second largest share in the segment.
"The Asia Pacific region is growing at the highest CAGR in the long-read sequencing market from 2024 to 2029."
The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the large scale of population genomics projects, and the demand for precision medicines is supporting the growth. Further, the rising prevalence of chronic diseases is attributed to the aging population of countries such as Japan, and China. These is supporting the adoption of sequencing technologies in healthcare prognosis and treatment driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%,
- By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.
List of Companies Profiled in the Report:
- Oxford Nanopore Technologies plc. (UK)
- PacBio (US)
- Illumina, Inc. (US)
- Agilent Technologies, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- 10X Genomics, Inc. (US)
- QIAGEN (Germany)
- BGI Group (China)
- Takara Bio Inc. (Japan)
- Azenta US, Inc. (US)
- Revvity, Inc. (US)
- Danaher Corporation (US)
- Novogene Co., Ltd. (China)
- New England Biolabs (US)
- BaseClear BV (Netherlands)
- Element Biosciences (US)
- Grandomics (China)
- CD Genomics (US)
- Sage Sciences, Inc. (US)
- EdenRoc Sciences (US)
Research Coverage:
This research report categorizes the long-read sequencing market by offerings (instruments, consumables, and services), technology (single-molecule real-time sequencing, nanopore sequencing, and synthetic long-read sequencing), workflow (sample preparation, sequencing, and data analysis), application (whole genome sequencing, metagenomics, epigenetics, targeted sequencing, whole exome sequencing, and other applications), usage (research and clinical), end user (academic & research institutes, pharmaceutical & biotechnology companies, hospitals, clinics & diagnostic Labs, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the long-read sequencing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as collaborations, expansions, agreements, and recent developments associated with the long-read sequencing market. Competitive analysis of top players and upcoming startups in the long-read sequencing market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall long-read sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
Analysis of key drivers (Technological advancements in genome sequencing, Increased prevalence of complex and rare genetic disorders, and growing demand for high-quality throughput screening), restraints (High investments to develop long read sequencing technologies, Technical Limitations of existing technology), opportunities (Rising demand for long-read sequencing in clinical genomics, and expanding applications of long-read sequencing), and challenges (challenges associated with data preservation, analysis, and validation) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched services of the long-read sequencing market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the long-read sequencing market
- Competitive Assessment: Oxford Nanopore Technologies plc. (UK), PacBio (US), Illumina, Inc. (US), Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), 10X Genomics, Inc. (US), QIAGEN (Germany), BGI Group (China), Takara Bio Inc. (Japan), Azenta US, Inc. (US), Revvity, Inc. (US), Danaher Corporation (US), Novogene Co., Ltd. (China), New England Biolabs (US), BaseClear BV (Netherlands), Element Biosciences (US), Grandomics (China), CD Genomics (US), Sage Sciences, Inc. (US), and EdenRoc Sciences (US) among others in the market.
1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS 32
1.3 MARKET SCOPE 33
1.3.1 MARKETS COVERED 33
1.3.2 YEARS CONSIDERED 34
1.3.3 CURRENCY CONSIDERED 34
1.4 STAKEHOLDERS 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
2.1.1 SECONDARY DATA 35
2.1.2 PRIMARY DATA 36
2.2 MARKET ESTIMATION METHODOLOGY 38
2.2.1 MARKET SIZE ESTIMATION 38
2.2.2 TOP-DOWN APPROACH 41
2.3 MARKET GROWTH RATE PROJECTIONS 42
2.4 DATA TRIANGULATION 44
2.5 RESEARCH ASSUMPTIONS 44
2.6 RESEARCH LIMITATIONS 45
2.7 RISK ANALYSIS 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 51
4.1 LONG-READ SEQUENCING MARKET OVERVIEW 51
4.2 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY OFFERING 52
4.3 LONG-READ SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 53
4.4 LONG-READ SEQUENCING MARKET SHARE, BY END USER, 2023 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
5.2.1 DRIVERS 55
5.2.1.1 Emerging technological advancements 55
5.2.1.2 Increasing prevalence of complex and rare genetic disorders 56
5.2.1.3 Growing demand for high-throughput sequencing 56
5.2.1.4 Expanding applications of long-read sequencing 57
5.2.2 RESTRAINTS 57
5.2.2.1 High investment cost 57
5.2.2.2 Technical limitations of existing technologies 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Rising adoption in clinical genomics 58
5.2.4 CHALLENGES 58
5.2.4.1 Data preservation, analysis, and validation issues 58
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 59
5.4 REGULATORY LANDSCAPE 59
5.4.1 REGULATORY SCENARIO 59
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
5.5 VALUE CHAIN ANALYSIS 62
5.6 TECHNOLOGICAL ANALYSIS 64
5.6.1 KEY TECHNOLOGIES 64
5.6.1.1 Single-molecule real-time sequencing 64
5.6.1.2 Nanopore sequencing 65
5.6.1.3 Synthetic long-read sequencing 65
5.6.2 COMPLEMENTARY TECHNOLOGIES 66
5.6.2.1 Next-generation sequencing combined with artificial intelligence 66
5.6.2.2 Single-cell sequencing 66
5.6.2.3 Polymerase chain reaction 66
5.6.3 ADJACENT TECHNOLOGIES 67
5.6.3.1 Sample preparation technologies 67
5.6.3.2 Data analysis 67
5.7 PRICING ANALYSIS 68
5.7.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY OFFERING 68
5.7.2 AVERAGE SELLING PRICE OF KEY PLAYERS, BY INSTRUMENT 68
5.7.3 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE 69
5.7.4 AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE 70
5.7.5 AVERAGE SELLING PRICE, BY REGION 71
5.8 PATENT ANALYSIS 72
5.9 SUPPLY CHAIN ANALYSIS 74
5.10 ECOSYSTEM ANALYSIS 75
5.11 KEY CONFERENCES & EVENTS, 2024-2025 77
5.12 PORTER'S FIVE FORCES ANALYSIS 78
5.12.1 PORTER'S FIVE FORCES ANALYSIS 78
5.12.2 INTENSITY OF COMPETITIVE RIVALRY 79
5.12.3 BARGAINING POWER OF SUPPLIERS 79
5.12.4 BARGAINING POWER OF BUYERS 79
5.12.5 THREAT OF SUBSTITUTES 79
5.12.6 THREAT OF NEW ENTRANTS 79
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 80
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 80
5.13.2 KEY BUYING CRITERIA, BY END USER 80
5.14 INVESTMENT & FUNDING SCENARIO 82
5.15 CASE STUDY ANALYSIS 82
5.15.1 ENHANCED DETECTION OF AMYOTROPHIC LATERAL SCLEROSIS USING PACBIO SINGLE-MOLECULE, REAL-TIME SEQUENCING 82
5.15.2 IMPROVED DIAGNOSIS OF RARE DISEASES WITH LONG-READ WHOLE-GENOME SEQUENCING 83
5.16 IMPACT OF AI ON LONG-READ SEQUENCING MARKET 83
6 LONG-READ SEQUENCING MARKET, BY OFFERING 84
6.1 INTRODUCTION 85
6.2 CONSUMABLES 85
6.2.1 LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE TO PROPEL DEMAND 85
6.3 INSTRUMENTS 88
6.3.1 ADVANCEMENTS IN LONG-READ SEQUENCING TECHNOLOGY TO BOOST MARKET GROWTH 88
6.4 SERVICES 91
6.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO FAVOR MARKET GROWTH 91
7 LONG-READ SEQUENCING MARKET, BY TECHNOLOGY 95
7.1 INTRODUCTION 96
7.2 NANOPORE SEQUENCING 96
7.2.1 DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH 96
7.3 SINGLE-MOLECULE REAL-TIME SEQUENCING 100
7.3.1 HIGHLY ACCURATE LONG READS BY REPEATEDLY SEQUENCING CIRCULARIZED DNA TO DRIVE DEMAND 100
7.4 SYNTHETIC LONG-READ SEQUENCING 103
7.4.1 GROWING DEMAND FOR DETAILED AND COMPREHENSIVE GENOMIC DATA IN AREAS SUCH AS CLINICAL GENOMICS TO BOOST MARKET 103
8 LONG-READ SEQUENCING MARKET, BY WORKFLOW 106
8.1 INTRODUCTION 107
8.2 SEQUENCING 107
8.2.1 DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH 107
8.3 SAMPLE PREPARATION 111
8.3.1 DEVELOPMENT OF ADVANCED LIBRARY PREPARATION SOLUTIONS TO BOOST MARKET 111
?
8.4 DATA ANALYSIS 114
8.4.1 DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO FAVOR MARKET GROWTH 114
9 LONG-READ SEQUENCING MARKET, BY APPLICATION 118
9.1 INTRODUCTION 119
9.2 WHOLE-GENOME SEQUENCING 119
9.2.1 INCREASING USE OF WGS IN RARE DISEASE RESEARCH TO DRIVE MARKET GROWTH 119
9.3 TARGETED SEQUENCING 123
9.3.1 RISING DEMAND FOR LONG-READ SEQUENCING IN DISEASE DIAGNOSTICS TO SUPPORT MARKET GROWTH 123
9.4 METAGENOMICS 126
9.4.1 GROWING DEMAND FOR HIGH-RESOLUTION AND ACCURATE METAGENOMIC DATA TO FUEL GROWTH 126
9.5 EPIGENETICS 129
9.5.1 ADVANTAGES OF LRS IN EPIGENETICS STUDIES TO BOOST DEMAND 129
9.6 WHOLE-EXOME SEQUENCING 132
9.6.1 GROWING DEMAND FOR PRECISION GENETICS TO FAVOR MARKET GROWTH 132
9.7 OTHER APPLICATIONS 135
10 LONG-READ SEQUENCING MARKET, BY USAGE 138
10.1 INTRODUCTION 139
10.2 RESEARCH USAGE 139
10.2.1 RISING RESEARCH COLLABORATIONS TO BOOST MARKET GROWTH 139
10.3 CLINICAL USAGE 142
10.3.1 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 142
11 LONG-READ SEQUENCING MARKET, BY END USER 146
11.1 INTRODUCTION 147
11.2 ACADEMIC & RESEARCH INSTITUTES 147
11.2.1 ACADEMIC & RESEARCH INSTITUTES TO DOMINATE MARKET DURING FORECAST PERIOD 147
11.3 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 151
11.3.1 GROWING COLLABORATIONS BETWEEN LRS PLAYERS AND PHARMA-BIOTECH COMPANIES TO DRIVE GROWTH 151
11.4 HOSPITALS, CLINICS, AND DIAGNOSTIC LABS 154
11.4.1 RISING DEMAND FOR LONG-READ SEQUENCING IN HOSPITALS & CLINICS TO SUPPORT GROWTH 154
11.5 OTHER END USERS 157
?
12 LONG-READ SEQUENCING MARKET, BY REGION 160
12.1 INTRODUCTION 161
12.2 NORTH AMERICA 162
12.2.1 US 165
12.2.1.1 US to dominate North American long-read sequencing market during forecast period 165
12.2.2 CANADA 168
12.2.2.1 Increasing government initiatives in genomics research to aid market growth 168
12.3 EUROPE 171
12.3.1 GERMANY 173
12.3.1.1 Increased funding for genomic development and application to favor market growth 173
12.3.2 UK 176
12.3.2.1 Favorable NHS funding and increased number of patients with rare genetic diseases to spur market growth 176
12.3.3 FRANCE 179
12.3.3.1 Increasing government investment in genomics and proteomics research to augment market growth 179
12.3.4 ITALY 181
12.3.4.1 Developed research infrastructure and increased genomics investment to fuel market growth 181
12.3.5 SPAIN 184
12.3.5.1 Advancements in translational and personalized medicine sector to boost market growth 184
12.3.6 REST OF EUROPE 186
12.4 ASIA PACIFIC 189
12.4.1 CHINA 193
12.4.1.1 Favorable regulatory reforms and high patient population to aid market growth 193
12.4.2 JAPAN 196
12.4.2.1 Technological advancements and high government investments in biotechnology to augment market growth 196
12.4.3 INDIA 198
12.4.3.1 Favorable government initiatives for genomics research to drive market 198
12.4.4 SOUTH KOREA 201
12.4.4.1 Rising government investments in cancer treatments and precision medicine to support market growth 201
12.4.5 REST OF ASIA PACIFIC 203
?
12.5 LATIN AMERICA 206
12.5.1 BRAZIL 209
12.5.1.1 Increased public and private investments in sequencing technologies to spur market growth 209
12.5.2 MEXICO 211
12.5.2.1 Growing prevalence of chronic disease and increasing geriatric population to support market growth 211
12.5.3 ARGENTINA 213
12.5.3.1 Rising healthcare investments and increasing focus on public health services to propel market growth 213
12.5.4 REST OF LATIN AMERICA 216
12.6 MIDDLE EAST 218
12.6.1 GCC COUNTRIES 221
12.6.1.1 Saudi Arabia 223
12.6.1.1.1 High government healthcare expenditure and technological advancements to boost market growth 223
12.6.1.2 UAE 226
12.6.1.2.1 Increasing R&D investment and growing healthcare infrastructure to aid market growth 226
12.6.1.3 Rest of GCC Countries 229
12.6.2 REST OF MIDDLE EAST 231
12.7 AFRICA 234
12.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET GROWTH 234
13 COMPETITIVE LANDSCAPE 237
13.1 INTRODUCTION 237
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 237
13.3 REVENUE ANALYSIS 239
13.4 MARKET SHARE ANALYSIS 240
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 243
13.5.1 STARS 243
13.5.2 EMERGING LEADERS 243
13.5.3 PERVASIVE PLAYERS 243
13.5.4 PARTICIPANTS 243
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 245
13.5.5.1 Company footprint 245
13.5.5.2 Region footprint 245
13.5.5.3 Offering footprint 246
13.5.5.4 Application footprint 247
13.5.5.5 Technology footprint 247
?
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 248
13.6.1 PROGRESSIVE COMPANIES 248
13.6.2 RESPONSIVE COMPANIES 248
13.6.3 DYNAMIC COMPANIES 248
13.6.4 STARTING BLOCKS 248
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 249
13.7 COMPANY VALUATION & FINANCIAL METRICS 250
13.8 BRAND/SERVICE COMPARISON 252
13.8.1 OXFORD NANOPORE TECHNOLOGIES PLC 252
13.8.2 PACBIO 253
13.8.3 ILLUMINA, INC. 253
13.8.4 AGILENT TECHNOLOGIES, INC. 253
13.8.5 THERMO FISHER SCIENTIFIC INC. 253
13.9 COMPETITIVE SCENARIO 253
13.9.1 DEALS 253
13.9.2 EXPANSIONS 254
14 COMPANY PROFILES 255
14.1 KEY PLAYERS 255
14.1.1 OXFORD NANOPORE TECHNOLOGIES PLC 255
14.1.1.1 Business overview 255
14.1.1.2 Products & services offered 256
14.1.1.3 Recent developments 257
14.1.1.3.1 Deals 257
14.1.1.4 MnM view 258
14.1.1.4.1 Right to win 258
14.1.1.4.2 Strategic choices 258
14.1.1.4.3 Weaknesses and competitive threats 258
14.1.2 PACBIO 259
14.1.2.1 Business overview 259
14.1.2.2 Products & services offered 260
14.1.2.3 Recent developments 262
14.1.2.3.1 Product & service launches 262
14.1.2.3.2 Deals 262
14.1.2.3.3 Expansions 263
14.1.2.3.4 Other developments 263
14.1.2.4 MnM view 264
14.1.2.4.1 Right to win 264
14.1.2.4.2 Strategic choices 264
14.1.2.4.3 Weaknesses and competitive threats 264
?
14.1.3 ILLUMINA, INC. 265
14.1.3.1 Business overview 265
14.1.3.2 Products & services offered 266
14.1.3.3 Recent developments 267
14.1.3.3.1 Product launches 267
14.1.3.4 MnM view 268
14.1.3.4.1 Key strengths 268
14.1.3.4.2 Strategic choices 268
14.1.3.4.3 Weaknesses and competitive threats 268
14.1.4 AGILENT TECHNOLOGIES, INC. 269
14.1.4.1 Business overview 269
14.1.4.2 Products & services offered 270
14.1.5 THERMO FISHER SCIENTIFIC INC. 272
14.1.5.1 Business overview 272
14.1.5.2 Products & services offered 273
14.1.6 10X GENOMICS, INC. 275
14.1.6.1 Business overview 275
14.1.6.2 Products & services offered 276
14.1.6.3 Recent developments 277
14.1.6.3.1 Product launches 277
14.1.7 QIAGEN 278
14.1.7.1 Business overview 278
14.1.7.2 Products & services offered 279
14.1.7.3 Recent developments 280
14.1.7.3.1 Expansions 280
14.1.8 BGI GROUP 281
14.1.8.1 Business overview 281
14.1.8.2 Products & services offered 281
14.1.9 AZENTA US, INC. 282
14.1.9.1 Business overview 282
14.1.9.2 Products & services offered 283
14.1.9.3 Recent developments 284
14.1.9.3.1 Expansions 284
14.1.10 TAKARA BIO INC. 285
14.1.10.1 Business overview 285
14.1.10.2 Products & services offered 286
14.1.10.3 Recent developments 287
14.1.10.3.1 Deals 287
14.1.11 NOVOGENE CO., LTD. 288
14.1.11.1 Business overview 288
14.1.11.2 Products & services offered 288
14.1.11.3 Recent developments 289
14.1.11.3.1 Other developments 289
14.1.12 REVVITY INC. 290
14.1.12.1 Business overview 290
14.1.12.2 Products & services offered 291
14.1.13 DANAHER CORPORATION 292
14.1.13.1 Business overview 292
14.1.13.2 Products & services offered 293
14.1.14 NEW ENGLAND BIOLABS 294
14.1.14.1 Business overview 294
14.1.14.2 Products & services offered 294
14.1.15 BASE CLEAR BV 295
14.1.15.1 Business overview 295
14.1.15.2 Products & services offered 295
14.2 OTHER PLAYERS 296
14.2.1 ELEMENT BIOSCIENCES 296
14.2.2 GRANDOMICS 296
14.2.3 CD GENOMICS 297
14.2.4 SAGE SCIENCES, INC. 298
14.2.5 EDENROC SCIENCES 298
15 APPENDIX 299
15.1 DISCUSSION GUIDE 299
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 303
15.3 CUSTOMIZATION OPTIONS 305
15.4 RELATED REPORTS 305
15.5 AUTHOR DETAILS 306
TABLE 1 INCLUSIONS & EXCLUSIONS 32
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 43
TABLE 3 LONG-READ SEQUENCING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 55
TABLE 4 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION 60
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 60
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY INSTRUMENT, 2021-2023 (USD) 68
TABLE 11 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE, 2021-2023 (USD) 69
TABLE 12 AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE, 2023 (USD) 70
TABLE 13 AVERAGE SELLING PRICE, BY REGION, 2021-2023 (USD) 71
TABLE 14 INNOVATIONS AND PATENT REGISTRATIONS, 2020-2024 73
TABLE 15 LONG-READ SEQUENCING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 76
TABLE 16 LONG-READ SEQUENCING MARKET: KEY CONFERENCES & EVENTS, 2024-2025 77
TABLE 17 LONG-READ SEQUENCING MARKET: IMPACT OF PORTER'S FIVE FORCES 78
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%) 80
TABLE 19 KEY BUYING CRITERIA, BY END USER 81
TABLE 20 LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION) 85
TABLE 21 LONG-READ SEQUENCING CONSUMABLES MARKET, BY REGION,
2022-2029 (USD MILLION) 86
TABLE 22 NORTH AMERICA: LONG-READ SEQUENCING CONSUMABLES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 86
TABLE 23 EUROPE: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 86
TABLE 24 ASIA PACIFIC: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 87
TABLE 25 LATIN AMERICA: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 87
TABLE 26 MIDDLE EAST: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 87
TABLE 27 GCC COUNTRIES: LONG-READ SEQUENCING CONSUMABLES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 88
TABLE 28 LONG-READ SEQUENCING INSTRUMENTS MARKET, BY REGION,
2022-2029 (USD MILLION) 89
TABLE 29 NORTH AMERICA: LONG-READ SEQUENCING INSTRUMENTS MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 89
TABLE 30 EUROPE: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 89
TABLE 31 ASIA PACIFIC: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 90
TABLE 32 LATIN AMERICA: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 90
TABLE 33 MIDDLE EAST: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 90
TABLE 34 GCC COUNTRIES: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 91
TABLE 35 LONG-READ SEQUENCING SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 92
TABLE 36 NORTH AMERICA: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 92
TABLE 37 EUROPE: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 92
TABLE 38 ASIA PACIFIC: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 93
TABLE 39 LATIN AMERICA: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 93
TABLE 40 MIDDLE EAST: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 93
TABLE 41 GCC COUNTRIES: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 94
TABLE 42 LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 96
TABLE 43 LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022-2029 (USD MILLION) 97
TABLE 44 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 97
TABLE 45 EUROPE: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING,
BY COUNTRY, 2022-2029 (USD MILLION) 98
TABLE 46 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 98
TABLE 47 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 99
TABLE 48 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 99
TABLE 49 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 99
TABLE 50 LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2022-2029 (USD MILLION) 100
TABLE 51 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 101
TABLE 52 EUROPE: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 101
TABLE 53 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 101
TABLE 54 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 102
TABLE 55 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 102
TABLE 56 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 102
TABLE 57 LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING,
BY REGION, 2022-2029 (USD MILLION) 103
TABLE 58 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 104
TABLE 59 EUROPE: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 104
TABLE 60 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 104
TABLE 61 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 105
TABLE 62 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 105
TABLE 63 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 105
TABLE 64 LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION) 107
TABLE 65 LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY REGION, 2022-2029 (USD MILLION) 108
TABLE 66 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 108
TABLE 67 EUROPE: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS,
BY COUNTRY, 2022-2029 (USD MILLION) 109
TABLE 68 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 109
TABLE 69 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 110
TABLE 70 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 110
TABLE 71 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 110
TABLE 72 LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS,
BY REGION, 2022-2029 (USD MILLION) 112
TABLE 73 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 112
TABLE 74 EUROPE: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 112
TABLE 75 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 113
TABLE 76 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 113
TABLE 77 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 113
TABLE 78 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 114
TABLE 79 LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS,
BY REGION, 2022-2029 (USD MILLION) 115
TABLE 80 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 115
TABLE 81 EUROPE: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 115
TABLE 82 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 83 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 84 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 85 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION) 117
TABLE 86 LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 119
TABLE 87 LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY REGION, 2022-2029 (USD MILLION) 120
TABLE 88 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 120
TABLE 89 EUROPE: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 121
TABLE 90 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 121
TABLE 91 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 122
TABLE 92 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 122
TABLE 93 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 122
TABLE 94 LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY REGION, 2022-2029 (USD MILLION) 123
TABLE 95 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 124
TABLE 96 EUROPE: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING,
BY COUNTRY, 2022-2029 (USD MILLION) 124
TABLE 97 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 124
TABLE 98 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 125
TABLE 99 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 125
TABLE 100 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 125
TABLE 101 LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY REGION,
2022-2029 (USD MILLION) 126
TABLE 102 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR METAGENOMICS,
BY COUNTRY, 2022-2029 (USD MILLION) 127
TABLE 103 EUROPE: LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION) 127
TABLE 104 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR METAGENOMICS,
BY COUNTRY, 2022-2029 (USD MILLION) 127
TABLE 105 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR METAGENOMICS,
BY COUNTRY, 2022-2029 (USD MILLION) 128
TABLE 106 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR METAGENOMICS,
BY COUNTRY, 2022-2029 (USD MILLION) 128
TABLE 107 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR METAGENOMICS,
BY COUNTRY, 2022-2029 (USD MILLION) 128
TABLE 108 LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY REGION,
2022-2029 (USD MILLION) 129
TABLE 109 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR EPIGENETICS,
BY COUNTRY, 2022-2029 (USD MILLION) 130
TABLE 110 EUROPE: LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY COUNTRY, 2022-2029 (USD MILLION) 130
TABLE 111 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY COUNTRY, 2022-2029 (USD MILLION) 130
TABLE 112 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR EPIGENETICS,
BY COUNTRY, 2022-2029 (USD MILLION) 131
TABLE 113 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR EPIGENETICS,
BY COUNTRY, 2022-2029 (USD MILLION) 131
TABLE 114 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR EPIGENETICS,
BY COUNTRY, 2022-2029 (USD MILLION) 131
TABLE 115 LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY REGION, 2022-2029 (USD MILLION) 132
TABLE 116 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 132
TABLE 117 EUROPE: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 133
TABLE 118 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 133
TABLE 119 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 134
TABLE 120 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 134
TABLE 121 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION) 134
TABLE 122 LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 135
TABLE 123 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 136
TABLE 124 EUROPE: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022-2029 (USD MILLION) 136
TABLE 125 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022-2029 (USD MILLION) 136
TABLE 126 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 137
TABLE 127 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022-2029 (USD MILLION) 137
TABLE 128 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 137
TABLE 129 LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION) 139
TABLE 130 LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE, BY REGION,
2022-2029 (USD MILLION) 140
TABLE 131 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 140
TABLE 132 EUROPE: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 140
TABLE 133 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 141
TABLE 134 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 141
TABLE 135 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 141
TABLE 136 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 137 LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY REGION,
2022-2029 (USD MILLION) 143
TABLE 138 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 143
TABLE 139 EUROPE: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY COUNTRY, 2022-2029 (USD MILLION) 143
TABLE 140 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 144
TABLE 141 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 144
TABLE 142 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 144
TABLE 143 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE,
BY COUNTRY, 2022-2029 (USD MILLION) 145
TABLE 144 LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION) 147
TABLE 145 LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2022-2029 (USD MILLION) 148
TABLE 146 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 148
TABLE 147 EUROPE: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 149
TABLE 148 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 149
TABLE 149 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 150
TABLE 150 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 150
TABLE 151 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 150
TABLE 152 LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 151
TABLE 153 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 152
TABLE 154 EUROPE: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 152
TABLE 155 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 152
TABLE 156 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 157 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 158 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 159 LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY REGION, 2022-2029 (USD MILLION) 154
TABLE 160 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION) 155
TABLE 161 EUROPE: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION) 155
TABLE 162 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION) 155
TABLE 163 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION) 156
TABLE 164 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION) 156
TABLE 165 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION) 156
TABLE 166 LONG-READ SEQUENCING MARKET FOR OTHER END USERS, BY REGION,
2022-2029 (USD MILLION) 157
TABLE 167 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,
BY COUNTRY, 2022-2029 (USD MILLION) 158
TABLE 168 EUROPE: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,
BY COUNTRY, 2022-2029 (USD MILLION) 158
TABLE 169 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,
BY COUNTRY, 2022-2029 (USD MILLION) 158
TABLE 170 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,
BY COUNTRY, 2022-2029 (USD MILLION) 159
TABLE 171 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,
BY COUNTRY, 2022-2029 (USD MILLION) 159
TABLE 172 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,
BY COUNTRY, 2022-2029 (USD MILLION) 159
TABLE 173 LONG-READ SEQUENCING MARKET, BY REGION, 2022-2029 (USD MILLION) 161
TABLE 174 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 163
TABLE 175 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 163
TABLE 176 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 163
TABLE 177 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 164
TABLE 178 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 164
TABLE 179 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 164
TABLE 180 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 165
TABLE 181 US: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION) 166
TABLE 182 US: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 166
TABLE 183 US: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 166
TABLE 184 US: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 167
TABLE 185 US: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION) 167
TABLE 186 US: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 167
TABLE 187 CANADA: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 169
TABLE 188 CANADA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 169
TABLE 189 CANADA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 169
TABLE 190 CANADA: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 170
TABLE 191 CANADA: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 170
TABLE 192 CANADA: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 170
TABLE 193 EUROPE: LONG-READ SEQUENCING MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 171
TABLE 194 EUROPE: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 171
TABLE 195 EUROPE: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 172
TABLE 196 EUROPE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 172
TABLE 197 EUROPE: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 172
TABLE 198 EUROPE: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 173
TABLE 199 EUROPE: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 173
TABLE 200 GERMANY: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 174
TABLE 201 GERMANY: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 174
TABLE 202 GERMANY: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 175
TABLE 203 GERMANY: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 175
TABLE 204 GERMANY: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 175
TABLE 205 GERMANY: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 176
TABLE 206 UK: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 177
TABLE 207 UK: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 177
TABLE 208 UK: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 177
TABLE 209 UK: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 178
TABLE 210 UK: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION) 178
TABLE 211 UK: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 178
TABLE 212 FRANCE: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 179
TABLE 213 FRANCE: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 179
TABLE 214 FRANCE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 180
TABLE 215 FRANCE: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 180
TABLE 216 FRANCE: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 180
TABLE 217 FRANCE: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 181
TABLE 218 ITALY: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 182
TABLE 219 ITALY: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 182
TABLE 220 ITALY: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 182
TABLE 221 ITALY: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 183
TABLE 222 ITALY: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION) 183
TABLE 223 ITALY: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 183
TABLE 224 SPAIN: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 184
TABLE 225 SPAIN: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 185
TABLE 226 SPAIN: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 185
TABLE 227 SPAIN: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 185
TABLE 228 SPAIN: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION) 186
TABLE 229 SPAIN: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 186
TABLE 230 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 187
TABLE 231 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 187
TABLE 232 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 188
TABLE 233 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 188
TABLE 234 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 188
TABLE 235 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 189
TABLE 236 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 191
TABLE 237 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 191
TABLE 238 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 191
TABLE 239 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 192
TABLE 240 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 192
TABLE 241 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 192
TABLE 242 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 193
TABLE 243 CHINA: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 194
TABLE 244 CHINA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 194
TABLE 245 CHINA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 194
TABLE 246 CHINA: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 195
TABLE 247 CHINA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION) 195
TABLE 248 CHINA: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 195
TABLE 249 JAPAN: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 196
TABLE 250 JAPAN: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 196
TABLE 251 JAPAN: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 197
TABLE 252 JAPAN: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 197
TABLE 253 JAPAN: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION) 197
TABLE 254 JAPAN: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 198
TABLE 255 INDIA: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 199
TABLE 256 INDIA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 199
TABLE 257 INDIA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 199
TABLE 258 INDIA: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 200
TABLE 259 INDIA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION) 200
TABLE 260 INDIA: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 200
TABLE 261 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 201
TABLE 262 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 202
TABLE 263 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 202
TABLE 264 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 202
TABLE 265 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 203
TABLE 266 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 203
TABLE 267 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 204
TABLE 268 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION) 204
TABLE 269 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 205
TABLE 270 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 205
TABLE 271 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 205
TABLE 272 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 206
TABLE 273 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 206
TABLE 274 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 207
TABLE 275 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 207
TABLE 276 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 207
TABLE 277 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 208
TABLE 278 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 208
TABLE 279 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 208
TABLE 280 BRAZIL: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 209
TABLE 281 BRAZIL: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 209
TABLE 282 BRAZIL: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 210
TABLE 283 BRAZIL: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 210
TABLE 284 BRAZIL: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 210
TABLE 285 BRAZIL: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 211
TABLE 286 MEXICO: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 211
TABLE 287 MEXICO: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 212
TABLE 288 MEXICO: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 212
TABLE 289 MEXICO: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 212
TABLE 290 MEXICO: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 213
TABLE 291 MEXICO: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 213
TABLE 292 ARGENTINA: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 214
TABLE 293 ARGENTINA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 214
TABLE 294 ARGENTINA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 214
TABLE 295 ARGENTINA: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 215
TABLE 296 ARGENTINA: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 215
TABLE 297 ARGENTINA: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 215
TABLE 298 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION) 216
TABLE 299 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION) 216
TABLE 300 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 217
TABLE 301 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 217
TABLE 302 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 217
TABLE 303 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION) 218
TABLE 304 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY REGION,
2022-2029 (USD MILLION) 218
TABLE 305 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 219
TABLE 306 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 219
TABLE 307 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 219
TABLE 308 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 220
TABLE 309 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 220
TABLE 310 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 220
TABLE 311 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 221
TABLE 312 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 221
TABLE 313 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 222
TABLE 314 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 222
TABLE 315 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 222
TABLE 316 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 223
TABLE 317 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 223
TABLE 318 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 224
TABLE 319 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 224
TABLE 320 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 225
TABLE 321 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 225
TABLE 322 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 225
TABLE 323 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 226
TABLE 324 UAE: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 227
TABLE 325 UAE: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 227
TABLE 326 UAE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 227
TABLE 327 UAE: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 228
TABLE 328 UAE: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION) 228
TABLE 329 UAE: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 228
TABLE 330 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION) 229
TABLE 331 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION) 230
TABLE 332 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 230
TABLE 333 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 230
TABLE 334 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 231
TABLE 335 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION) 231
TABLE 336 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 232
TABLE 337 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION) 232
TABLE 338 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 233
TABLE 339 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 233
TABLE 340 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 233
TABLE 341 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 234
TABLE 342 AFRICA: LONG-READ SEQUENCING MARKET, BY OFFERING,
2022-2029 (USD MILLION) 235
TABLE 343 AFRICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,
2022-2029 (USD MILLION) 235
TABLE 344 AFRICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 235
TABLE 345 AFRICA: LONG-READ SEQUENCING MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 236
TABLE 346 AFRICA: LONG-READ SEQUENCING MARKET, BY USAGE,
2022-2029 (USD MILLION) 236
TABLE 347 AFRICA: LONG-READ SEQUENCING MARKET, BY END USER,
2022-2029 (USD MILLION) 236
TABLE 348 OVERVIEW OF STRATEGIES ADOPTED BY KEY LONG-READ SEQUENCING COMPANIES 237
TABLE 349 LONG-READ SEQUENCING MARKET: DEGREE OF COMPETITION 242
TABLE 350 LONG-READ SEQUENCING MARKET: REGION FOOTPRINT 245
TABLE 351 LONG-READ SEQUENCING MARKET: OFFERING FOOTPRINT 246
TABLE 352 LONG-READ SEQUENCING MARKET: APPLICATION FOOTPRINT 247
TABLE 353 LONG-READ SEQUENCING MARKET: TECHNOLOGY FOOTPRINT 247
TABLE 354 LONG-READ SEQUENCING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 249
TABLE 355 LONG-READ SEQUENCING MARKET: COMPANY FOOTPRINT (STARTUPS/SMES) 250
TABLE 356 LONG-READ SEQUENCING MARKET: DEALS, JANUARY 2021-JUNE 2024 253
TABLE 357 LONG-READ SEQUENCING MARKET: EXPANSIONS, JANUARY 2021-JUNE 2024 254
TABLE 358 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW 255
TABLE 359 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS & SERVICES OFFERED 256
TABLE 360 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2021-JUNE 2024 257
TABLE 361 PACBIO: COMPANY OVERVIEW 259
TABLE 362 PACBIO: PRODUCTS & SERVICES OFFERED 260
TABLE 363 PACBIO: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-JUNE 2024 262
TABLE 364 PACBIO: DEALS, JANUARY 2021-JUNE 2024 262
TABLE 365 PACBIO: EXPANSIONS, JANUARY 2021-JUNE 2024 263
TABLE 366 PACBIO: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2024 263
TABLE 367 ILLUMINA, INC.: COMPANY OVERVIEW 265
TABLE 368 ILLUMINA, INC.: PRODUCTS & SERVICES OFFERED 266
TABLE 369 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024 267
TABLE 370 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 269
TABLE 371 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED 270
TABLE 372 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 272
TABLE 373 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED 273
TABLE 374 10X GENOMICS, INC.: COMPANY OVERVIEW 275
TABLE 375 10X GENOMICS, INC.: PRODUCTS & SERVICES OFFERED 276
TABLE 376 10X GENOMICS, INC.: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024 277
TABLE 377 QIAGEN: COMPANY OVERVIEW 278
TABLE 378 QIAGEN: PRODUCTS & SERVICES OFFERED 279
TABLE 379 QIAGEN: EXPANSIONS, JANUARY 2021-JUNE 2024 280
TABLE 380 BGI GROUP: COMPANY OVERVIEW 281
TABLE 381 BGI GROUP: PRODUCTS & SERVICES OFFERED 281
TABLE 382 AZENTA US, INC.: COMPANY OVERVIEW 282
TABLE 383 AZENTA US, INC.: PRODUCTS & SERVICES OFFERED 283
TABLE 384 AZENTA US, INC.: EXPANSIONS, JANUARY 2021-JUNE 2024 284
TABLE 385 TAKARA BIO INC.: COMPANY OVERVIEW 285
TABLE 386 TAKARA BIO INC.: PRODUCTS & SERVICES OFFERED 286
TABLE 387 TAKARA BIO INC.: DEALS, JANUARY 2021-JUNE 2024 287
TABLE 388 NOVOGENE CO., LTD.: COMPANY OVERVIEW 288
TABLE 389 NOVOGENE CO., LTD.: PRODUCTS & SERVICES OFFERED 288
TABLE 390 NOVOGENE CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2024 289
TABLE 391 REVVITY, INC.: COMPANY OVERVIEW 290
TABLE 392 REVVITY INC.: PRODUCTS & SERVICES OFFERED 291
TABLE 393 DANAHER CORPORATION: COMPANY OVERVIEW 292
TABLE 394 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED 293
TABLE 395 NEW ENGLAND BIOLABS: COMPANY OVERVIEW 294
TABLE 396 NEW ENGLAND BIOLABS: PRODUCTS & SERVICES OFFERED 294
TABLE 397 BASE CLEAR BV: COMPANY OVERVIEW 295
TABLE 398 BASE CLEAR BV: PRODUCTS & SERVICES OFFERED 295
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security